Insights Landing
All Insights

Get Our Latest Insights Direct to Your Mailbox

Subscribe

LathamTECH in Focus Video Series

The Book of Jargon Series – Word of the Day®

The Book of Jargon® is a series of practice area and industry-specific glossaries published by Latham & Watkins.

DAT File

a Load File that contains Metadata associated with ESI and is typically used for loading documents into Review Platforms.

Word of the Day®

In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.

Listen here or subscribe via Apple PodcastsSpotify, or anywhere else you listen to podcasts.

Connected With Latham

Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation

      0:0050:18
        All Episodes

      Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation

      Loading...

      50:18

      Episode 96 – The Growth Rocketship: Shield AI’s Takeoff Shows What’s Possible in Defensetech

      Loading...

      52:23

      Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE

      Loading...

      22:14

      Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook

      Loading...

      22:13

      Episode 93 – EU’s Digital Operational Resilience Act: What You Should Know and How to Stay Compliant

      Loading...

      19:34

      Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends

      Loading...

      29:45

      Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets

      Loading...

      20:32

      Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets

      Loading...

      23:23

      Episode 89 – The Growth Rocketship: How BridgeBio’s Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What’s Next?

      Loading...

      47:21

      Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?

      Loading...

      33:12

      Episode 87 – Drug Pricing: What’s In the New CMS Medicaid Final Rule?

      Loading...

      28:38

      Episode 86 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

      Loading...

      18:25

      Episode 85 – Drug Pricing: How The Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry

      Loading...

      21:48

      Episode 84 – Pro Bono: Shabir Kabiri’s Remarkable Journey from Afghanistan to Asylum in the US

      Loading...

      34:22

      Episode 83 – Drug Pricing: How Are Payers Responding to the IRA?

      Loading...

      29:16

      Episode 82 – Drug Pricing: Takeaways from the New Orleans Pricing and Contracting USA Conference

      Loading...

      17:31

      Episode 81 – Drug Pricing: A Look Behind the Curtain of the New ASP Reporting Website and Other Data Collection Portals

      Loading...

      23:35

      Episode 80 – Energy & Infrastructure: Why is Energy Tech So Attractive to Venture Capital?

      Loading...

      26:13

      Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration

      Loading...

      16:03

      Episode 78 – UK FinReg Focus Areas in 2024: ESG

      Loading...

      17:12

      Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals

      Loading...

      8:23

      Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence

      Loading...

      17:49

      Episode 75 – UK FinReg Focus Areas in 2024: Enforcement Against Firms

      Loading...

      13:24

      Episode 74 – UK FinReg Focus Areas in 2024: Conduct and Culture

      Loading...

      13:19

      Episode 73 – UK FinReg Focus Areas in 2024: Artificial Intelligence

      Loading...

      13:54

      Episode 72 – UK FinReg Focus Areas in 2024: The Edinburgh Reforms

      Loading...

      10:18

      Episode 71 – Drug Pricing: A Look Ahead at Trends for 2024

      Loading...

      11:48

      Episode 70 – UK FinReg Focus Areas in 2024: Investment Research

      Loading...

      17:14

      Episode 69 – UK FinReg Focus Areas in 2024: Retail Markets – Direction of Travel

      Loading...

      13:49

      Episode 68 – Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?

      Loading...

      13:39

      Episode 67 – PE Views: The Most Pressing Cybersecurity Considerations For Private Equity

      Loading...

      33:59

      Episode 66 – UK FinReg Focus Areas in 2024: Primary Markets Reform

      Loading...

      13:54

      Episode 65 – PE Views: How Can PE Sponsors Promote Transparency and Successful Fund Raise Amid ESG Scrutiny?

      Loading...

      9:51

      Episode 64 – Energy & Infrastructure: How Can Companies Avoid Greenwashing Allegations and ESG Litigation Risks?

      Loading...

      25:52

      Episode 63 – M&A Views: How Should Deal Teams Navigate a Global Crackdown on Restrictive Covenants?

      Loading...

      13:57

      Episode 62 – Has FDA Meaningfully Changed Its Restrictions on Off-Label Communications?

      Loading...

      26:26

      Episode 61 – Drug Pricing: New OIG Guidance Reaffirms the Seven Elements of an Effective Compliance Program

      Loading...

      12:45

      Episode 60 – PE Views: Is the CMA’s Focus on Roll-Up Transactions Here to Stay?

      Loading...

      10:28

      Episode 59 – SCOTUS Update: Perez v. Sturgis Secures a Supreme Court Win for Disability Rights

      Loading...

      37:08

      Episode 58 – FDI Developments: M&A Security Screening in Europe's Fragmented FDI Landscape

      Loading...

      19:36

      Episode 57 – Drug Pricing: What Trends Emerged from the 2023 Medicaid Drug Rebate Program Summit?

      Loading...

      12:12

      Episode 56 – M&A Views: Avoiding Buyer’s Remorse in M&A Deals

      Loading...

      13:25

      Episode 55 – Insurtech: What Should Startups Do After Receiving FCA Authorization?

      Loading...

      8:37

      Episode 54 – Drug Pricing: Focus on Best Price — CMS Proposed Rule, Inflation Reduction Act

      Loading...

      13:17

      Episode 53 – Energy & Infrastructure: Can Sustainable Finance Fuel the Energy Transition?

      Loading...

      18:05

      Episode 52 – Drug Pricing: Could a Single Reference Price Apply Across a Therapeutic Class?

      Loading...

      11:16

      Episode 51 – Drug Pricing: Final IRA Price Negotiation Guidance – How CMS Addressed the Part D/B Problem

      Loading...

      10:53

      Episode 50 – PE Views: Under New Reforms, Is the Customer Always Right?

      Loading...

      12:48

      Episode 49 – PE Views: Will Greenwashing Rain on the UK PE Parade?

      Loading...

      17:29

      Episode 48 – M&A Views: Will UK-Bound M&A Need to Come to US Terms?

      Loading...

      11:53

      Episode 47 – Real Estate Realities in Europe: Expensive Money and the Power of Private Equity

      Loading...

      12:20

      Episode 46 – PE Views: PE Must Strike the Right Balance With Unions

      Loading...

      12:30

      Episode 45 – Will Insurtech Reach New Heights in 2023?

      Loading...

      8:31

      Episode 44 – PE Views: Private Equity Looks to Share-Based Schemes to Incentivise Non-Managerial Staff

      Loading...

      13:16

      Episode 43 – Energy & Infrastructure: The Drivers and Opportunities of Asia’s Digital Infrastructure Boom

      Loading...

      19:27

      Episode 42 – PE Views: Has Rethinking Cannabis Sparked PE Interest?

      Loading...

      9:28

      Episode 41 – PE Views: Why Do Music Deals Sound So Attractive to PE?

      Loading...

      13:39

      Episode 40 – PE Views: Could PE Benefit From the Universal Adoption of “Super Senior” RCFs in Leveraged Financings?

      Loading...

      10:43

      Episode 39 – New FDA Commissioner Dr. Califf: What His Appointment Means for the Regulated Industry and What to Watch for in 2022

      Loading...

      20:05

      Episode 38 – PE Views: How are ESG Regulatory Reforms and Investor Focus Shaping the Market?

      Loading...

      16:07

      Episode 37 – Energy & Infrastructure: What’s Behind The Wave of ESG Shareholder Activism?

      Loading...

      24:28

      Episode 36 – Fintech Focus: The Year in Crypto – What Changed and What Comes Next in 2022?

      Loading...

      30:44

      Episode 35 – PE Views: Is Gaming the Next Level for Private Equity?

      Loading...

      9:05

      Episode 34 – Fintech Focus: What’s Next for Hong Kong and Singapore in 2022?

      Loading...

      24:46

      Episode 33 – PE Views: How is Creative Collateral Use Changing PE Finance Options?

      Loading...

      14:35

      Episode 32 – PE Views: Will UK IPOs with Dual Class Shares Surface New PE Opportunities?

      Loading...

      9:49

      Episode 31 – PE Views: How is Growth Equity Connecting PE and VC?

      Loading...

      15:54

      Episode 30 – PE Views: Has the Pandemic Increased Whistleblowing Risks?

      Loading...

      10:08

      Episode 29 – Energy & Infrastructure: What’s Driving the Oil & Gas Evolution in Europe?

      Loading...

      17:50

      Episode 28 – Energy & Infrastructure: What’s the View From Inside the DOE Loan Programs Office?

      Loading...

      44:03

      Episode 27 – Energy & Infrastructure: How Will EP4 Affect Projects in High-Income Countries?

      Loading...

      16:42

      Episode 26 – Energy & Infrastructure: Will the Market Sustain Its Interest in Sustainability-Linked Bonds?

      Loading...

      19:40

      Episode 25 – Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?

      Loading...

      19:42

      Episode 24 – Energy & Infrastructure: How Will the Biden Administration’s Goals Affect the Energy Transition?

      Loading...

      16:28

      Episode 23 – Energy & Infrastructure: Renewables Driving Change in the Investment Landscape

      Loading...

      12:46

      Episode 22 – PE Views: Foreign Investment Controls – Are We Seeing a More Nuanced Approach to Private Equity?

      Loading...

      12:47

      Episode 21 – Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?

      Loading...

      29:24

      Episode 20 – Healthcare Tech: How Will the FDA Regulatory Framework Adapt to AI?

      Loading...

      29:19

      Episode 19 – Copyright & Brexit: How Will Article 15 of the EU Copyright Directive Affect Publishers and Platforms‪?

      Loading...

      17:37

      Episode 18 – Tech Trends: Has the Tide Turned for Transatlantic Data Transfers Post-Schrems II?

      Loading...

      21:41

      Episode 17 – Copyright & Brexit: Will the UK Copy the EU Directive or Develop Its Own Regime?

      Loading...

      17:22

      Episode 16 – Insolvency Reform: Spotting and Mitigating Future Risk in Supply Relationships

      Loading...

      22:50

      Episode 15 – Healthcare Tech: What Legal Pitfalls Should Tech Companies Avoid As They Jump Into Healthcare?

      Loading...

      22:28

      Episode 14 – Fintech Focus: Crypto in the Crosshairs – What Regulatory Themes Characterized 2020?

      Loading...

      26:21

      Episode 13 – Fintech Focus: How Did Singapore Solidify Its Position as a Leading Fintech Hub in 2020?

      Loading...

      16:11

      Episode 12 – Fintech Focus: Payments During the Pandemic – What Key Legal and Regulatory Themes Emerged During 2020?

      Loading...

      26:12

      Episode 11 – Restructuring in Asia: How Will Chinese Bond Defaults Resolve?

      Loading...

      21:44

      Episode 10 – PE Views: The Lipstick Effect — Why Are Beauty Deals Increasingly Attractive for Private Equity?

      Loading...

      9:03

      Episode 9 – Tech Trends: CCPA and the Next Wave of Data Privacy Regimes

      Loading...

      20:14

      Episode 8 – Corporate Culture: How to Attain Sustainable Change

      Loading...

      27:22

      Episode 7 – Brexit & Financial Services: Preparing for the End of the Transition Period

      Loading...

      36:46

      Episode 6 – Tech Trends: Tech M&A – How Has the Pandemic Changed the Market?

      Loading...

      21:06

      Episode 5 – Insolvency Reform: Termination on Ipso Facto of Supply Contracts

      Loading...

      18:20

      Episode 4 – The ABCs of ESG: How Are Companies Going Beyond the Basics?

      Loading...

      20:18

      Episode 3 – Tech Trends: AI is Here. Now, can we teach the robots ethics and legal compliance?

      Loading...

      26:21

      Episode 2 – Tech Trends: How Does Growth Debt Fuel Startups Between Equity Rounds?

      Loading...

      17:35

      Episode 1 – Tech Trends: IPO or Direct Listing?

      Loading...

      11:05
      From Our Blogs